Profile data is unavailable for this security.
About the company
Mono Pharmacare Limited is an India-based company, which is a distributor and supplier of a wide array of pharmaceutical products and medicines. The Company offers health care products, antibiotic medicines, cough cold anti allergic medicines, antifungal medicines, nutraceutical medicines, analgesic and antipyretic medicines, antacid and antiemetics medicines, cardiac - diabetic medicines, and Cosmo care products. The Company’s segments are Marketing of Pharmaceutical Products, and Distributor of Pharmaceuticals Companies. Its portfolio comprises a wide range of drugs like antibiotics, antifungal, anti-cough cold and anti-allergic, antacid and antiemetics, analgesics and antipyretics, nutraceuticals, skincare, antiseptic, cardiac, diabetic and cosmetics.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated2022
- Employees--
- LocationMono Pharmacare LtdAHMEDABAD 380007IndiaIND
- Websitehttps://monopharmacareltd.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vivimed Labs Ltd | 1.47bn | -3.17bn | 410.42m | 607.00 | -- | -- | -- | 0.2783 | -38.77 | -38.77 | 17.88 | -- | -- | -- | -- | 2,429,737.00 | -- | -5.92 | -- | -8.97 | -62.46 | 33.74 | -214.73 | -14.20 | -- | -6.31 | -- | -- | -21.15 | -30.83 | -385.64 | -- | -- | -- |
Vineet Laboratories Ltd | 1.37bn | 1.46m | 545.21m | -- | 335.54 | 1.66 | 20.30 | 0.3952 | 0.1749 | 0.1749 | 148.76 | 35.35 | -- | -- | -- | -- | -- | -- | -- | -- | 25.44 | -- | 0.107 | -- | 0.4833 | 0.7313 | 0.565 | -- | -29.06 | -- | -18.00 | -- | -- | -- |
Mono Pharmacare Ltd | -100.00bn | -100.00bn | 617.52m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 58.12 | -- | 251.10 | -- | -- | -- |
JFL Life Sciences Ltd | -100.00bn | -100.00bn | 725.90m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.63 | -- | 50.42 | -- | -- | -- |
Medicamen Organics Ltd | 252.72m | 24.04m | 772.20m | 112.00 | 32.12 | 5.09 | 24.72 | 3.06 | 2.05 | 2.05 | 21.60 | 12.98 | -- | -- | -- | 2,256,402.00 | -- | -- | -- | -- | 42.12 | -- | 9.51 | -- | 0.9695 | 7.04 | 0.4546 | -- | 14.11 | -- | 91.93 | -- | -- | -- |